CD47
CD47proteinCD47 'don't-eat-me' signal suppresses macrophage phagocytosis; altered CD47 expression or signaling modulates plaque inflammation and leukocyte activity.
Pathway placement
Cascade stepPlaque inflammation
Confidencemedium
RationaleDon't-eat-me signal regulating macrophage phagocytosis and immune activation.
Also acts inPlatelet activation
Druggability
DruggableYes
Known drugs / candidates2
Small-molecule tractableNo
Antibody tractableYes
EnsemblENSG00000196776
Type I vs Type II discrimination
ScoresLow-confidence (proxy)
R — rupture / Type-I49
C — confounder / Type-II80
A — assay feasibility72
E — evidence strength30
T1DI (composite)7
Specificity differential (R−C)-31.2
Confounder panel (Type-II drivers)
No confounder evidence retrieved.
Tier: light (literature co-occurrence proxy — lower confidence). See the discrimination table for all markers.
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)
Literature evidence(1)
- Subacute treatment of carprofen facilitate splenocardiac resolution deficit in cardiac injury.Journal of leukocyte biology · 2018 · PMID 30145840 · doi